Clinical Patterns of Primary Biliary Cholangitis: Comparison Between Two European Case Series

被引:2
作者
Abenavoli, Ludovico [1 ]
Procopio, Anna Caterina [1 ]
Cinaglia, Pietro [1 ]
Zanza, Christian [2 ]
Delle Grazie, Claudio [1 ]
Longhitano, Yaroslava [2 ]
Libicherova, Pavla [3 ,4 ]
Luzza, Francesco [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
[2] Michele & Pietro Ferrero Hosp, Osped Alba Bra Onlus, Dept Emergency Med Anesthesia & Crit Care Med, Verduno, CN, Italy
[3] Charles Univ Prague, Dept Hepatol, Fac Med 3, Prague, Czech Republic
[4] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, PraguePrague, Czech Republic
关键词
Liver disease; autoimmunity; therapy; ursodeoxycholic acid; primary biliary cholangitis; biliary epithelial injury; RISK-FACTORS; URSODEOXYCHOLIC ACID; CIRRHOSIS; EPIGENETICS; DISEASE; UDCA; FXR;
D O I
10.2174/1574887117666220617095856
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease characterized by progressive destruction of the intrahepatic bile ducts, followed by fibrous substitution of the ducts and potential evolution in cirrhosis. The geographical disparity in the prevalence of PBC suggests a possible role of environmental factors in developing the disease. We analyzed two groups of patients with different geographical prevalence. Methods This study concerned the analysis of 14 Caucasian patients in two groups: ten patients enrolled in the Digestive Diseases Unit, University of Catanzaro (Italy), and four patients enrolled in the Department of Hepatology, University Hospital Kralovske Vinohrady of Prague (Czech Republic). The statistical analysis was performed using the software IBM SPSS (v. 20, Windows). Results The Italian group showed a statistically significant difference in the total bilirubin values at diagnosis and during the last control (0.74 +/- 0.267 vs. 0.56 +/- 0.246; p-value: 0.013). Moreover, the comparison between the two groups showed a statistically significant difference in the serum albumin values at the time of the last control (4.6 +/- 0.231 vs. 4.15 +/- 0.532; p-value: 0.048). Conclusion Our data indicate an effective difference in the onset and clinical presentation between our two groups. More epidemiologic, prospective, and multicenter research projects are warranted to advance PBC knowledge in Europe.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 30 条
[1]   Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists [J].
Abenavoli, Ludovico ;
Procopio, Anna Caterina ;
Fagoonee, Sharmila ;
Pellicano, Rinaldo ;
Carbone, Marco ;
Luzza, Francesco ;
Invernizzi, Pietro .
DISEASES, 2020, 8 (02)
[2]   Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel [J].
Alvaro, Domenico ;
Carpino, Guido ;
Craxi, Antonio ;
Floreani, Annarosa ;
Moschetta, Antonio ;
Invernizzi, Pietro .
LIVER INTERNATIONAL, 2020, 40 (11) :2590-2601
[3]  
Bergasa Nora V, 2003, Clin Liver Dis, V7, P879, DOI 10.1016/S1089-3261(03)00105-3
[4]   New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond [J].
Beuers, Ulrich ;
Trauner, Michael ;
Jansen, Peter ;
Poupon, Raoul .
JOURNAL OF HEPATOLOGY, 2015, 62 :S25-S37
[5]   Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence [J].
Bosch, Alexie ;
Dumortier, Jerome ;
Maucort-Boulch, Delphine ;
Scoazec, Jean-Yves ;
Wendum, Dominique ;
Conti, Filomena ;
Morard, Isabelle ;
Rubbia-Brandt, Laura ;
Terris, Benoit ;
Radenne, Sylvie ;
Abenavoli, Ludovico ;
Poupon, Raoul ;
Chazouilleres, Olivier ;
Calmus, Yvon ;
Boillot, Olivier ;
Giostra, Emiliano ;
Corpechot, Christophe .
JOURNAL OF HEPATOLOGY, 2015, 63 (06) :1449-1458
[6]   Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis [J].
Bossen, Lars ;
Rebora, Paola ;
Bernuzzi, Francesca ;
Jepsen, Peter ;
Gerussi, Alessio ;
Andreone, Pietro ;
Galli, Andrea ;
Terziroli, Benedetta ;
Alvaro, Domenico ;
Labbadia, Giancarlo ;
Aloise, Chiara ;
Baiocchi, Leonardo ;
Giannini, Edoardo ;
Abenavoli, Ludovico ;
Toniutto, Pierluigi ;
Marra, Fabio ;
Marzioni, Marco ;
Niro, Grazia ;
Floreani, Annarosa ;
Moller, Holger J. ;
Valsecchi, Maria G. ;
Carbone, Marco ;
Gronbaek, Henning ;
Invernizzi, Pietro .
LIVER INTERNATIONAL, 2020, 40 (06) :1408-1414
[7]   Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis [J].
Cheung, Angela C. ;
LaRusso, Nicholas F. ;
Gores, Gregory J. ;
Lazaridis, Konstantinos N. .
SEMINARS IN LIVER DISEASE, 2017, 37 (02) :159-174
[8]   A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis [J].
Corpechot, C. ;
Chazouilleres, O. ;
Rousseau, A. ;
Le Gruyer, A. ;
Habersetzer, F. ;
Mathurin, P. ;
Goria, O. ;
Potier, P. ;
Minello, A. ;
Silvain, C. ;
Abergel, A. ;
Debette-Gratien, M. ;
Larrey, D. ;
Roux, O. ;
Bronowicki, J. -P. ;
Boursier, J. ;
de Ledinghen, V. ;
Heurgue-Berlot, A. ;
Nguyen-Khac, E. ;
Zoulim, F. ;
Ollivier-Hourmand, I. ;
Zarski, J. -P. ;
Nkontchou, G. ;
Lemoinne, S. ;
Humbert, L. ;
Rainteau, D. ;
Lefevre, G. ;
de Chaisemartin, L. ;
Chollet-Martin, S. ;
Gaouar, F. ;
Admane, F. -H. ;
Simon, T. ;
Poupon, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (23) :2171-2181
[9]   Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis [J].
Corpechot, Christophe ;
Abenavoli, Ludovico ;
Rabahi, Nabila ;
Chretien, Yves ;
Andreani, Tony ;
Johanet, Catherine ;
Chazouilleres, Olivier ;
Poupon, Raoul .
HEPATOLOGY, 2008, 48 (03) :871-877
[10]   New treatments/targets for primary biliary cholangitis [J].
Corpechot, Christophe ;
Poupon, Raoul ;
Chazouilleres, Olivier .
JHEP REPORTS, 2019, 1 (03) :203-213